- Home
- REKR vs MCRB Comparison
REKR vs MCRB Comparison
Compare REKR & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REKR | MCRB |
|---|---|---|
| Founded | 2017 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 104.5M | 85.7M |
| IPO Year | 2017 | 2015 |
Fundamental Metrics
Financial Performance| Metric | REKR | MCRB |
|---|---|---|
| Price | $0.80 | $7.86 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 3.1M | 52.0K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 4.35 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $9,234,000.00 | $789,000.00 |
| Revenue This Year | $12.51 | N/A |
| Revenue Next Year | $23.49 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $6.56 |
| 52 Week High | $3.42 | $29.98 |
Technical Indicators
Market Signals| Indicator | REKR | MCRB |
|---|---|---|
| Relative Strength Index (RSI) | 42.82 | 45.56 |
| Support Level | $0.75 | $6.56 |
| Resistance Level | $0.96 | $8.29 |
| Average True Range (ATR) | 0.07 | 0.57 |
| MACD | -0.00 | 0.08 |
| Stochastic Oscillator | 8.57 | 72.11 |
Price Performance
Historical ComparisonAbout REKR Rekor Systems Inc.
Rekor Systems Inc is a United States-based company. The company is engaged in providing real-time roadway intelligence through AI-driven decisions. The firm uses artificial intelligence to analyze video streams and transform them into AI-driven decisions. The company's technology and machine learning models power all solutions, including Rekor Command for transportation management, Rekor Discover for urban mobility, and Rekor Scout for public safety, and commercial use. Its geographical segments are the United States and Others, of which a majority of its revenue comes from the United States.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.